2770-5838

Portal Hypertension & Cirrhosis

Wiley (John Wiley & Sons)

View prefix report (10.1002)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 112 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact112 DOIs
2

Add abstracts to 74 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact74 DOIs
3

Deposit reference lists for 44 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact44 DOIs

DOIs for this ISSN

Showing the top 5 of 160 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Global scientific trends on portal hypertension and cirrhosi… (10.1002/poh2.42)
Abstract ORCID
38.91 5
2 Sarcopenic obesity in liver disease: Handling both sides of… (10.1002/poh2.10)
ORCID
30.76 16
3 Thirty years' transjugular intrahepatic portosystemic stent‐… (10.1002/poh2.7)
Abstract ORCID
30.10 3
4 Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment f… (10.1002/poh2.100)
ORCID
27.85 12
5 T cells and liver fibrosis (10.1002/poh2.11)
ORCID
25.00 9
6 The natural history of patients with compensated cirrhosis a… (10.1002/poh2.27)
ORCID
25.00 9
7 Application of graph theory in liver research: A review (10.1002/poh2.97)
ORCID
21.13 6
8 Non‐hemodynamic effects: Repurposing of nonselective beta‐bl… (10.1002/poh2.22)
Abstract
19.45 5
9 Hepatic venous pressure gradient measurement guiding nonsele… (10.1002/poh2.47)
ORCID
19.45 5
10 Hepatic venous pressure gradient (HVPG) measurement: Tips an… (10.1002/poh2.9)
Abstract
19.45 5
11 Molecular mechanisms of hepatic lipid metabolism disorders:… (10.1002/poh2.95)
ORCID
19.45 5
12 Portal vein thrombosis in liver cirrhosis: An updated overvi… (10.1002/poh2.46)
ORCID
17.47 4
13 The Prognostic Significance of Handgrip Strength in Cirrhosi… (10.1002/poh2.70006)
ORCID
17.47 4
14 Impact of endoscopic ultrasound examination for deep esophag… (10.1002/poh2.19)
ORCID
15.05 3
15 The launch of <i>Portal Hypertension &amp; Cirrhosis</i> in… (10.1002/poh2.21)
Abstract ORCID
15.05 1
16 Noninvasive diagnosis of liver fibrosis in schistosomiasis j… (10.1002/poh2.38)
Abstract ORCID
15.05 1
17 Noncirrhotic portal hypertension misdiagnosed as liver cirrh… (10.1002/poh2.39)
Abstract ORCID
15.05 1
18 Subharmonic aided pressure estimation in portal hypertension… (10.1002/poh2.45)
Abstract
15.05 3
19 Investigation on the short‐term outcome and prognostic impac… (10.1002/poh2.53)
ORCID
15.05 3
20 Capsule endoscopy in portal hypertension and varices (10.1002/poh2.87)
Abstract ORCID
15.05 1
21 Both APRI and FIB‐4 could effectively evaluate liver fibrosi… (10.1002/poh2.34)
Abstract
11.93 2
22 Comparison of patients with hepatitis B virus‐associated hep… (10.1002/poh2.60)
ORCID
11.93 2
23 Sleep disturbances in patients with cirrhosis: Pursuing just… (10.1002/poh2.61)
ORCID
11.93 2
24 Progress in the diagnosis and treatment of graft fibrosis af… (10.1002/poh2.70)
ORCID
11.93 2
25 Effects of Shunt Position on the Prognosis of Transjugular I… (10.1002/poh2.70014)
ORCID
11.93 2
26 Management of non‐cirrhotic extrahepatic portal vein obstruc… (10.1002/poh2.23)
Abstract
7.53 1
27 PH&amp;C: A new journey in Liverland (10.1002/poh2.5)
Abstract
7.53 1
28 The Role of Magnesium in Liver Cirrhosis (10.1002/poh2.70007)
ORCID
7.53 1
29 Radiological Organ Age Reveals Accelerated Aging of the Live… (10.1002/poh2.70025)
ORCID
7.53 1
30 Chinese Expert Consensus on the Use of Ultrasound‐Derived Fa… (10.1002/poh2.70042)
ORCID
7.53 1
31 Serum markers for detecting histological features of autoimm… (10.1002/poh2.71)
ORCID
7.53 1
32 Innovations in endoscopic ultrasound for portal hypertension… (10.1002/poh2.74)
ORCID
7.53 1
33 Issue Information (10.1002/poh2.1)
Abstract References ORCID
0.00 0
34 Research Progress of Noninvasive Evaluation of Portal Hypert… (10.1002/poh2.101)
ORCID
0.00 0
35 A case of agnogenic intrahepatic arterioportal fistula compl… (10.1002/poh2.12)
ORCID
0.00 0
36 Issue Information (10.1002/poh2.13)
Abstract References ORCID
0.00 0
37 Issue Information (10.1002/poh2.14)
Abstract References ORCID
0.00 0
38 Issue Information (10.1002/poh2.15)
Abstract References ORCID
0.00 0
39 Issue Information (10.1002/poh2.16)
Abstract References ORCID
0.00 0
40 Endothelins and liver cirrhosis (10.1002/poh2.17)
0.00 7
41 Nonselective beta‐blockers reduce mortality in patients with… (10.1002/poh2.18)
0.00 12
42 Issue Information (10.1002/poh2.2)
Abstract References ORCID
0.00 0
43 Trained innate immunity and human adenovirus infection as a… (10.1002/poh2.20)
ORCID
0.00 0
44 Comparison of survival prediction values of different scorin… (10.1002/poh2.24)
0.00 3
45 Splenic artery embolization for treatment of portal hyperten… (10.1002/poh2.25)
0.00 0
46 Transforming one organ into another to overcome challenges i… (10.1002/poh2.26)
0.00 5
47 A comprehensive review of prognostic scoring systems to pred… (10.1002/poh2.28)
0.00 2
48 Simultaneous splenectomy improving the outcomes of patients… (10.1002/poh2.29)
0.00 1
49 Issue Information (10.1002/poh2.3)
Abstract References ORCID
0.00 0
50 Liver cirrhosis in Japan: Future global trends in the era of… (10.1002/poh2.30)
0.00 1